Clinical Trials and Case Reports

To fully appreciate the complexity and challenges in interpreting hypertension trials, it is informative to review their evolution. The prospective, randomized, clinical trial has been the foundation for evaluating the effectiveness of blood pressure-lowering drugs. The duration of clinical trials rarely exceeds five years, and trials focus on so-called “hard end points”—notably, all-cause mortality and/or cause specific morbidity and mortality due to CVD, usually coronary heart disease (CHD) and/or stroke, but more recently heart failure (HF) as well.

The early clinical trials had the advantage of being able to compare “active therapy” with placebo and usually included patients with more severe hypertension, as compared with modern trials. Consequently, they generated more end points and had sufficient power to be conducted on a smaller scale than modern trials high blood pressure is often called a "silent disease" because people usually don't know they have it; there may be no outward symptoms or a sign, so monitoring the blood pressure is critical. Treating high blood pressure can take a multi-pronged approach including diet changes, medication, and exercise. Hypertension treatment comes in many forms -- from lifestyle changes to medication.

  • Integrating lifestyle advice into clinical management
  • Clinical practice guidelines for the management of overweight and obesity
  • Data management and statistical analysis and data validation processes
  • Meta-analysis of blood pressure-lowering drug trials
  • Reporting blood pressure parameters in clinical trails
  • Surrogate or intermediate disease markers
  • Assessment of overall cardiovascular risk in hypertensive patients
  • Primary biliary cirrhosis

Related Conference of Clinical Trials and Case Reports

February 19-21, 2018

23rd European Heart Disease and Heart Failure Congress

Paris, France
April 19-20, 2018

3rd World Heart Congress

Amsterdam, Netherlands
November 19-20, 2018

29th World Cardiology Conference

Edinburgh, Scotland
May 14-16, 2018

2nd World Heart Congress

Tokyo, Japan
June 11-13, 2018

24th Annual Cardiologists Conference

Barcelona, Spain
July 12-13, 2018

Global Cardiology Summit

Bangkok, Thailand
August 09-10, 2018

26th Annual Cardiology and Cardiovascular  Nursing Congress

Manila, Philippines
September 10-11, 2018

4th International Conference on Hypertension & Healthcare

Zurich, Switzerland
September 11-12, 2018

World Cardiology and Cardiologist Meeting

Stockholm, Sweden
September 14-15, 2018

4th Global Summit on Heart Diseases

Singapore
17-18 September,2018

24th World Cardiology Conference

Hong Kong
September 17-18,2018

25th Annual Cardiologists Conference

Tin Shui Wai,Hong Kong
September 21-22, 2018

27th International Conference on Clinical & Experimental Cardiology Research

Vancouver, British Columbia, Canada
September 24-26, 2018

5th World Heart and Brain conference

Abu Dhabi, UAE
October 05-06, 2018

Current and Future trends in Cardio Vascular Diseases: Research and Outcomes

Los Angeles, California, USA
October 19-20, 2018

Annual Congress on Cancer and Stem Cell Research

Baltimore, Maryland, USA
October 22-24, 2018

27th European Cardiology Conference

Rome, Italy
October 25-27, 2018

World Heart Rhythm Conference

Istanbul, Turkey
November 5-6, 2018

28thWorld Congress on Cardiology and Heart Diseases

Amsterdam, Netherlands

Clinical Trials and Case Reports Conference Speakers

Recommended Sessions

Related Journals

Are you interested in